Drug Type Polymer |
Synonyms- |
Action agonists |
Mechanism 5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (30 Jun 2026), |
Regulation- |
Molecular FormulaC16H21N3O2 |
InChIKeyULSDMUVEXKOYBU-ZDUSSCGKSA-N |
CAS Registry139264-17-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Migraine Disorders | Australia | 30 Jun 2026 |





